Albert Heck is a world expert in proteomics: determining which proteins are in our cells and how they work together to make us live. He does this using mass spectrometry. His research team works on developing new innovative ways to measure even faster, even more, and even better. In 2017, he was awarded the Spinoza prize, the highest scientific honour in the Netherlands.
Albert Heck collaborates with researchers at home and abroad. He was one of the founders of both the Netherlands Proteomics Center and the European cooperation area PRIME-XS. Heck is also part of the NWO Gravitation Programme Institute for Chemical Immunology and one of the partners of the major European research program MSMed, which aims to develop protein analysis in hospitals.
Albert Heck received many international awards for his work, including the Descartes Huygens Award from the Republique Francaise (2007), the NGI Distinguished Visiting Scientist (2010-2011), the Life Science Award of the German Mass Spectrometry Society (2010), the HUPO Discovery Award in Proteomic Sciences (2013), the EuPA Pioneer in Proteomics Award (2014) and the American Chemical Society 'Frank H. Field and Joe L. Franklin Award for Outstanding Achievements in Mass Spectrometry' (2015). In 2014 he was elected as a member of both the Royal Dutch Academy of Sciences and of the European Academy of Life Sciences, EMBO.